riluzole has been researched along with Dyskinesia, Medication-Induced in 7 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Pagliaroli, L | 2 |
| Fothi, A | 1 |
| Nespoli, E | 2 |
| Liko, I | 1 |
| Veto, B | 1 |
| Devay, P | 1 |
| Szeri, F | 1 |
| Hengerer, B | 2 |
| Barta, C | 2 |
| Aranyi, T | 1 |
| Widomska, J | 1 |
| Hildebrandt, T | 1 |
| Glennon, J | 1 |
| Poelmans, G | 1 |
| Lundblad, M | 1 |
| Usiello, A | 1 |
| Carta, M | 1 |
| Håkansson, K | 1 |
| Fisone, G | 1 |
| Cenci, MA | 1 |
| Bara-Jimenez, W | 1 |
| Dimitrova, TD | 1 |
| Sherzai, A | 1 |
| Aksu, M | 1 |
| Chase, TN | 1 |
| Merims, D | 2 |
| Ziv, I | 2 |
| Djaldetti, R | 2 |
| Melamed, E | 2 |
| Vale, S | 1 |
| Sherki, Y | 1 |
1 trial available for riluzole and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Glutamate release inhibition ineffective in levodopa-induced motor complications.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administrati | 2006 |
6 other studies available for riluzole and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes.
Topics: Animals; Corpus Striatum; DNA Methylation; Dyskinesia, Drug-Induced; Levodopa; Rats; Rats, Wistar; R | 2021 |
Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dyskinesia, Drug-Induc | 2019 |
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
Topics: Adenosine A2 Receptor Agonists; Adrenergic Agents; Amantadine; Animals; Antiparkinson Agents; Basal | 2005 |
Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; N | 1999 |
Drug treatments of levodopa-induced dyskinesias.
Topics: Amantadine; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid A | 1999 |
The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches.
Topics: Anticonvulsants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino A | 2001 |